Net Cash Provided by (Used in) Financing Activities of ENZO BIOCHEM INC from 31 Jul 2011 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ENZO BIOCHEM INC quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Jul 2011 to 31 Oct 2024.
  • ENZO BIOCHEM INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Oct 2024 was $200,000, a 61% increase year-over-year.
  • ENZO BIOCHEM INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,193,000, a 273% decline from 2023.
  • ENZO BIOCHEM INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,125,000, a 367% decline from 2022.
  • ENZO BIOCHEM INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $241,000, a 0.41% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ENZO BIOCHEM INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $200,000 +$318,000 +61% 01 Aug 2024 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q3 2023 $518,000 -$423,000 -445% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q3 2022 $95,000 -$38,000 -67% 01 Aug 2022 31 Oct 2022 10-Q 15 Dec 2023 2024 Q1
Q3 2021 $57,000 +$56,000 +50% 01 Aug 2021 31 Oct 2021 10-Q 12 Dec 2022 2023 Q1
Q3 2020 $113,000 +$58,000 +34% 01 Aug 2020 31 Oct 2020 10-Q 15 Dec 2021 2022 Q1
Q3 2019 $171,000 -$137,000 -403% 01 Aug 2019 31 Oct 2019 10-Q 11 Dec 2020 2021 Q1
Q3 2018 $34,000 -$591,000 -106% 01 Aug 2018 31 Oct 2018 10-Q 10 Dec 2019 2019 Q1
Q3 2017 $557,000 +$254,000 +84% 01 Aug 2017 31 Oct 2017 10-Q 10 Dec 2018 2019 Q1
Q3 2016 $303,000 +$428,000 01 Aug 2016 31 Oct 2016 10-Q 07 Dec 2017 2018 Q1
Q3 2015 $125,000 -$2,332,000 -106% 01 Aug 2015 31 Oct 2015 10-Q 08 Dec 2016 2017 Q1
Q3 2014 $2,207,000 +$238,000 +12% 01 Aug 2014 31 Oct 2014 10-Q 08 Dec 2015 2015 Q1
Q3 2013 $1,969,000 +$1,997,000 01 Aug 2013 31 Oct 2013 10-Q 09 Dec 2014 2015 Q1
Q3 2012 $28,000 +$5,000 +15% 01 Aug 2012 31 Oct 2012 10-Q 10 Dec 2013 2014 Q1
Q3 2011 $33,000 01 Aug 2011 31 Oct 2011 10-Q 10 Dec 2012 2013 Q1

ENZO BIOCHEM INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,193,000 -$3,068,000 -273% 01 Aug 2023 31 Jul 2024 10-K 29 Oct 2024 2024 FY
2023 $1,125,000 -$884,000 -367% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 $241,000 +$1,000 +0.41% 01 Aug 2021 31 Jul 2022 10-K 03 Nov 2023 2023 FY
2021 $242,000 -$7,243,000 -103% 01 Aug 2020 31 Jul 2021 10-K 14 Oct 2022 2022 FY
2020 $7,001,000 +$2,808,000 +67% 01 Aug 2019 31 Jul 2020 10-K 14 Oct 2022 2022 FY
2019 $4,193,000 +$3,634,000 +650% 01 Aug 2018 31 Jul 2019 10-K 12 Oct 2021 2021 FY
2018 $559,000 +$2,228,000 01 Aug 2017 31 Jul 2018 10-K 19 Oct 2020 2020 FY
2017 $1,669,000 +$262,000 +14% 01 Aug 2016 31 Jul 2017 10-K 15 Oct 2019 2019 FY
2016 $1,931,000 -$8,156,000 -131% 01 Aug 2015 31 Jul 2016 10-K 15 Oct 2018 2018 FY
2015 $6,225,000 -$4,692,000 -43% 01 Aug 2014 31 Jul 2015 10-K 27 Sep 2017 2017 FY
2014 $10,917,000 +$6,102,000 +127% 01 Aug 2013 31 Jul 2014 10-K 13 Oct 2016 2016 FY
2013 $4,815,000 +$4,969,000 01 Aug 2012 31 Jul 2013 10-K 13 Oct 2015 2015 FY
2012 $154,000 -$86,000 -126% 01 Aug 2011 31 Jul 2012 10-K 09 Oct 2014 2014 FY
2011 $68,000 01 Aug 2010 31 Jul 2011 10-K 15 Oct 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.